Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion

Molecular Nutrition and Food Research

Volumn 57, Issue 5, 2013, Pages 886-895

  Hong, Bo Han ^a   Wu, Chi Hao ^b   Yeh, Chi Tai ^b   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

6 Shogaol; Breast cancer; Invadopodia; Metastasis; Pterostilbene

Indexed keywords

ACTIN; CATECHOL DERIVATIVE; CORTACTIN; CSK TYROSINE PROTEIN KINASE; CSK TYROSINE-PROTEIN KINASE; CTTN PROTEIN, HUMAN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MMP14 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; NUCLEAR PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN TYROSINE KINASE; PTEROSTILBENE; SHOGAOL; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; DRUG EFFECT; HUMAN; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CATECHOLS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CORTACTIN; HUMANS; IMMUNOPRECIPITATION; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NUCLEAR PROTEINS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RNA, MESSENGER; SRC-FAMILY KINASES; STILBENES; TWIST TRANSCRIPTION FACTOR;

EID: 84876431098     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200715     Document Type: Article

References (43)

1. Douglass, S., Ali, S., Meeson, A. P., Browell, D., Kirby, J. A., The role of FOXP3 in the development and metastatic spread of breast cancer. Cancer Metast. Rev. 2012, 31, 843-854.
2. Fidler, I. J., Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment. J. Natl. Cancer Inst. 2001, 93, 1040-1041.
3. Eckhardt, B. L., Francis, P. A., Parker, B. S., Anderson, R. L., Strategies for the discovery and development of therapies for metastatic breast cancer. Nat. Rev. Drug Discov. 2012, 11, 479-497.
4. Huang, Y., Simms, A. E., Mazur, A., Wang, S. et al., Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Clin. Exp. Metastas. 2011, 28, 567-579.
5. Nelson, A. R., Fingleton, B., Rothenberg, M. L., Matrisian, L. M., Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 2000, 18, 1135-1149.
6. Kelly, T., Mueller, S. C., Yeh, Y., Chen, W. T, Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J. Cell Physiol. 1994, 158, 299-308.
7. Balzer, E. M., Whipple, R. A., Thompson, K., Boggs, A. E. et al., c-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene 2010, 29, 6402-6408.
8. Oser, M., Yamaguchi, H., Mader, C. C., Bravo-Cordero, J. J. et al., Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J. Cell Biol. 2009, 186, 571-587.
9. Seals, D. F., Azucena, E. F. Jr., Pass, I., Tesfay, L. et al., The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005, 7, 155-165.
10. Weaver, A. M., Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastas. 2006, 23, 97-105.
11. Munaut, C., Noël, A., Hougrand, O., Foidart, J. M. et al., Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int. J. Cancer 2003, 106, 848-855.
12. Chen, W. T., Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 1996, 49, 59-71.
13. Yang, J., Mani, S. A., Donaher, J. L, Ramaswamy, S. et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 11, 7927-7939.
14. Eckert, M. A., Lwin, T. M., Chang, A. T., Kim, J. et al., Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011, 19, 372-386.
15. Bourguignon, L. Y., Wong, G., Earle, C., Krueger, K., Spevak, C. C., Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J. Biol. Chem. 2010, 285, 36721-36735.
16. Artym, V. V., Zhang, Y., Seillier-Moiseiwitsch, F., Yamada, K. M., Mueller, S. C., Dynamic interactions of cortactin and membrane type 1 metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006, 66, 3034-3043.
17. Kawasaki, B. T., Hurt, E. M., Mistree, T., Farrar, W. L., Targeting cancer stem cells with phytochemicals. Mol. Interv. 2008, 8, 174-184.
18. Levy, A. S., Simon, O., Shelly, J., Gardener, M., 6-Shogaol reduced chronic inflammatory response in the knees of rats treated with complete Freund's adjuvant. BMC Pharmacol. 2006, 6, 12-20.
19. Park, K. K., Chun, K. S., Lee, J. M., Lee, S. S., Surh, Y. J., Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Lett. 1998, 129, 139-144.
20. Lantz, R. C., Chen, G. J., Sarihan, M., Solyom, A. M. et al., The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007, 14, 123-128.
21. Pan, M. H., Hsieh, M. C., Kuo, J. M., Lai, C. S. et al., 6-Shogaol induces apoptosis in human colorectal carcinoma cells via ROS production, caspase activation, and GADD 153 expression. Mol. Nutr. Food Res. 2008, 52, 527-537.
22. Weng, C. J., Wu, C. F., Huang, H. W., Ho, C. T., Yen, G. C., Anti-invasion effects of 6-shogaol and 6-gingerol, two active components in ginger, on human hepatocarcinoma cells. Mol. Nutr. Food Res. 2010, 54, 1618-1627.
23. Soleas, G. J., Diamandis, E. P., Goldberg, D. M., Resveratrol: a molecule whose time has come? and gone? Clin. Biochem. 1997, 30, 91-113.
24. Rimando, A. M., Nagmani, R., Feller, D. R., Yokoyama, W., Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J. Agric. Food Chem. 2005, 53, 3403-3407.
25. Pan, M. H., Lin, Y. T., Lin, C. L., Wei, C. S. et al., Suppression of Heregulin-{beta}1/HER2-modulated invasive and aggressive phenotype of breast carcinoma by pterostilbene via inhibition of matrix metalloproteinase-9, p38 kinase Cascade and Akt activation. Evid. Based Complement Alternat. Med. 2011, 1-12.
26. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
27. Yeh, C. T., Wu, C. H., Yen, G. C., Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol. Nutr. Food Res. 2010, 54, 1285-1295.
28. Weng, C. J., Wu, C. F., Huang, H. W., Wu, C. H. et al., Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J. Agric. Food Chem. 2010, 58, 2886-2894.
29. Weng, C. J., Chau, C. F., Hsieh, Y. S., Yang, S. F., Yen, G. C., Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 2008, 29, 147-156.
30. Ling, H., Yang, H., Tan, S. H., Chui, W. K., Chew, E. H., 6-Shogaol, an active constituent of ginger, inhibits breast cancer cell invasion by reducing matrix metalloproteinase-9 expression via blockade of nuclear factor-κB activation. Br. J. Pharmacol. 2010, 161, 1763-1777.
31. Mannal, P., McDonald, D., McFadden, D., Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro. Am. J. Surg. 2010, 200, 577-580.
32. Alosi, J. A., McDonald, D. E., Schneider, J. S., Privette, A. R., McFadden, D. W., Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis. J. Surg. Res. 2010, 161, 195-201.
33. Sen, T., Dutta, A., Chatterjee, A., Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs 2010, 21, 632-644.
34. Castelló, R., Estellés, A., Vázquez, C., Falcó, C. et al., Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Clin. Chem. 2002, 48, 1288-1295.
35. Eckert, M. A., Yang, J., Targeting invadopodia to block breast cancer metastasis. Oncotarget 2011, 2, 562-568.
36. Björklund, M., Koivunen, E., Gelatinase-mediated migration and invasion of cancer cells. Biochim. Biophys. Acta 2005, 1755, 37-69.
37. Lee, H. S., Seo, E. Y., Kang, N. E., Kim, W. K., 6-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J. Nutr. Biochem. 2008, 19, 313-319.
38. Zick, S. M., Djuric, Z., Ruffin, M. T., Litzinger, A. J. et al., Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidem Biomar 2008, 17, 1930-1936.
39. Tao, Y., Li, W., Liang, W., Van Breemen, R. B., Identification and quantification of gingerols and related compounds in ginger dietary supplements using high-performance liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 2009, 57, 10014-10021.
40. Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., McCormick, D. L., Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother. Pharmacol. 2011, 68, 593-601.
41. Yu, Y., Zick, S., Li, X., Zou, P. et al., Examination of the pharmacokinetics of active ingredients of ginger in humans. AAPS J. 2011, 13, 417-426.
42. Jiang, S. Z., Wang, N. S., Mi, S. Q., Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Biopharm. Drug Dispos. 2008, 29, 529-537.
43. Chen, H., Lv, L., Soroka, D., Warin, R. F. et al., Metabolism of [6]-shogaol in mice and in cancer cells. Drug Metab. Dispos. 2012, 40, 742-753.